IQGAP1 and cancer: Considering the clinical utility of claudin expression as a prognostic marker in variety of human cancers60-62 and the link between TJ disruption and metastatic disease,63 our work suggests that IQGAP1 could be a potential therapeutic target in advanced cancers.